KEPPRA 100 mg/ml, oral solution bottle, 150 ml, CIP 3400939827599
Brand page: Keppra (levetiracetam) — all forms and strengths in France
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 150 ml, CIP 3400939827599orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KEPPRA 100 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun avec fermeture de sécurité enfant de 150 ml avec seringue(s) doseuse(s) de 3 ml
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60132330CIP73982759CIP133400939827599Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMsolution | 100 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.